Editorial Policies
Ethical standards governing CNS cancer research publication at JBSC.
Commitment to Research Integrity
JBSC maintains rigorous ethical standards aligned with COPE guidelines. These policies ensure integrity, transparency, and fairness throughout the publication process.
All research manuscripts undergo rigorous peer review by qualified neuro-oncology experts. Reviewers are selected based on expertise and absence of conflicts. JBSC uses single-blind review. Decisions are based solely on scientific merit.
Animal Research
Studies using animals require institutional ethics approval with compliance with relevant guidelines.
Human Subjects
Research involving patients requires ethics approval and informed consent documentation.
Data Integrity
Authors are responsible for accuracy of all data. Fabrication and falsification constitute misconduct.
All authors must meet ICMJE criteria: substantial contributions to conception or design, drafting or revising, final approval, and accountability. Gift authorship and ghost authorship are prohibited.
Disclosure Required: All authors must disclose financial or personal relationships that could influence research including device company funding and consulting relationships.
Allegations are investigated following COPE flowcharts. Responses may include rejection, retraction, or institutional notification.
Authors may appeal rejection decisions within 30 days with detailed justification. Editor-in-Chief reviews appeals within 4-6 weeks.
Errors discovered after publication should be reported promptly. Corrections are published as appropriate following COPE guidelines.
JBSC aims for initial decisions within 4-6 weeks. Complex reviews may require additional time. Authors receive status updates.
JBSC operates transparently, publishing editorial policies and review approaches publicly. We welcome questions about processes.
Editors select reviewers based on expertise, availability, and absence of conflicts. Author suggestions may be consulted. We aim for reviewer diversity across institutions.
Authors must provide Data Availability Statements. Repository deposition is encouraged. Restrictions due to privacy should be explained clearly.
Extended datasets, imaging series, and protocols can be submitted as supplementary materials undergoing peer review with permanent DOIs.
JBSC encourages sufficient methodological detail for replication. Key reagents, protocols, and methods should be described clearly enabling independent verification by readers.
Published articles may receive post-publication comments addressing methodology or interpretation. JBSC investigates concerns following guidelines and publishes responses when warranted.
Authors conducting confirmatory studies may preregister hypotheses and methods demonstrating commitment to rigorous and transparent research practices.
Prospective clinical studies must be registered in ICMJE-approved registries before enrollment with registration number prominently in abstract for verification.
Human and animal studies require appropriate ethics committee approval documented in methods section.
All funding sources must be disclosed including institutional support, grants, and industry sponsorship.
